Gliknik

Discovering and developing innovative biologics for immune disorders and cancers

placeBaltimore, Maryland, United States calendar_todayFounded 2007 groups6 employees language gliknik.com

Registered entities

Innovation

16 patent families (11 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 4,956 times.

YearFilings
20155
20166
20178
201810
20197
20209
20216
20226
20236
20248
20255
20261

Investor mix

8 investors on record; lead investors include Brace Pharma Capital, Pfizer, First In Ventures.

Investor typeCountShare
Venture capital563%
Private equity113%
Other / undisclosed225%
Coming soon